Echelard; Yann

Patent Applications and Registrations

Patent applications and USPTO patent grants for Echelard; Yann.The latest application filed is for "compositions and methods for prevention of photoaging".

Company Profile

0.1.23

Echelard; Yann - Jamaica Plains MA
Echelard; Yann - Jamaica Plain MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Prevention Of Photoaging App 20120263663 - Bernstein; Eric F. ; et al.	2012-10-18
Method Of Using An Anti-cd137 Antibody As An Agent For Radioimmunotherapy Or Radioimmunodetection App 20120058047 - Strome; Scott E. ; et al.	2012-03-08
Method Of Using An Anti-cd137 Antibody As An Agent For Radioimmunotherapy Or Radioimmunodetection App 20110104049 - Strome; Scott E. ; et al.	2011-05-05
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection App 20080019905 - Strome; Scott E. ; et al.	2008-01-24
Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin App 20080004212 - Echelard; Yann ; et al.	2008-01-03
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection App 20060188439 - Strome; Scott E. ; et al.	2006-08-24
Method for the rapid selection of homozygous primary cell lines for the production of transgenic animals by somatic cell nuclear transfer App 20060191025 - Echelard; Yann ; et al.	2006-08-24
Anti-CD137 antibody as an agent in the treatment of cancer and glycosylation variants thereof App 20060182744 - Strome; Scott E. ; et al.	2006-08-17
Methods and vectors for improving nucleic acid expression App 20060179500 - Meade; Harry M. ; et al.	2006-08-10
Methods of prescreening cells for nuclear transfer procedures App 20060123500 - Echelard; Yann ; et al.	2006-06-08
Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin App 20060121004 - Echelard; Yann ; et al.	2006-06-08
Transgenically produced fusion proteins App 20060026695 - Edge; Michael D. ; et al.	2006-02-02
Method of using recombinant human antithrombin for neurocognitive disorders App 20050245444 - Echelard, Yann ; et al.	2005-11-03
Compositions and methods for prevention of photoaging App 20050208000 - Bernstein, Eric F. ; et al.	2005-09-22
Somatic cell line App 20050193431 - Echelard, Yann ; et al.	2005-09-01
Methods of producing a target molecule in a transgenic animal and purification of the target molecule App 20040226053 - Meade, Harry M. ; et al.	2004-11-11
Methods of producing a target molecule in a transgenic animal and purification of the target molecule App 20040226052 - Meade, Harry M. ; et al.	2004-11-11
Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer App 20040148648 - Behboodi, Esmail ; et al.	2004-07-29
Transgenically produced fusion proteins App 20040117863 - Edge, Michael D. ; et al.	2004-06-17
Method for the rapid selection of homozygous primary cell lines for the production of transgenic animals by somatic cell nuclear transfer App 20040025193 - Echelard, Yann ; et al.	2004-02-05
Transgenic and cloned mammals App 20030177513 - Echelard, Yann ; et al.	2003-09-18
Methods of reconstructed goat embryo transfer Grant 6,580,017 - Echelard , et al. June 17, 2	2003-06-17
Transgenically produced platelet derived growth factor App 20030046716 - Echelard, Yann ; et al.	2003-03-06
Methods and vectors for improving nucleic acid expression App 20030005468 - Meade, Harry M. ; et al.	2003-01-02

Company Registrations

SEC

0001561958

Echelard Yann

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.